Article Details
Retrieved on: 2022-12-24 11:30:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer: U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer's Respiratory Syncytial Virus Vaccine Candidate for the ...
Article found on: indiaeducationdiary.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here